Condition
Thoracic Radiotherapy
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Recruiting1
Not Yet Recruiting1
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07037680Phase 2Recruiting
Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT
NCT06897189Not Yet Recruiting
Optimizing Radiation Dose and Utilizing Wearable Devices to Reduce Arrhythmia Risk in Patients Undergoing Thoracic Radiotherapy: A Prospective Cohort Study
NCT04462276Phase 2Completed
Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease
NCT03565120Not ApplicableUnknown
Aggressive Thoracic Radiotherapy for Stage Ⅳ Non Small Cell Lung Cancer
Showing all 4 trials